Studies test whether gene-editing can fix high cholesterol. For now, take your medicine
AI Summary
Scientists are exploring gene-editing as a potential one-time treatment for high cholesterol, a major risk factor for heart disease. Early research by companies like CRISPR Therapeutics focuses on "switching off" specific genes, such as ANGPTL3 and PCSK9, known to influence cholesterol levels. These genes were identified through studies of individuals with naturally low cholesterol. The goal is to offer an alternative to lifelong medication like statins, which can have side effects and adherence challenges. While promising, this research is in its early stages, with clinical trials underway to assess the safety and efficacy of these gene-editing approaches. For now, doctors recommend patients continue managing their cholesterol with existing medications.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).
Topic Connections
Explore how the topics in this article connect to other news stories